Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73826 - 73850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	AKR1C1	1645	upregulated	Silver results in increased expression of AKR1C1 mRNA	10p15.1	A24218
Silver	Approved Investigational	APLP2	334	upregulated	Silver results in increased expression of APLP2 mRNA	11q24.3	A24216
Silver	Approved Investigational	ASCL1	429	downregulated	Silver results in decreased expression of ASCL1 mRNA	12q23.2	A24216
Silver	Approved Investigational	ASS1	445	upregulated	Silver analog results in increased expression of ASS1 mRNA	9q34.11	A24215
Silver	Approved Investigational	BAX	581	upregulated	Silver results in increased expression of BAX mRNA	19q13.33	A24219
Silver	Approved Investigational	BCL2	596	downregulated	Silver results in decreased expression of BCL2 mRNA	18q21.33	A24219
Silver	Approved Investigational	BCL2L2	599	downregulated	Silver results in decreased expression of BCL2L2 mRNA	14q11.2	A24219
Silver	Approved Investigational	BDNF	627	upregulated	Silver results in increased expression of BDNF mRNA	11p14.1	A24216
Silver	Approved Investigational	BID	637	upregulated	Silver results in increased expression of BID mRNA	22q11.21	A24219
Silver	Approved Investigational	BPTF	2186	downregulated	Silver results in decreased expression of BPTF mRNA	17q24.2	A24216
Silver	Approved Investigational	C5	727	downregulated	Silver results in decreased expression of C5 mRNA	9q33.2	A24217
Silver	Approved Investigational	CASP4	837	upregulated	Silver results in increased expression of CASP4 mRNA	11q22.3	A24217
Silver	Approved Investigational	CAT	847	upregulated	Silver results in increased expression of CAT mRNA	11p13	A24220
Silver	Approved Investigational	CD55	1604	upregulated	Silver results in increased expression of CD55 mRNA	1q32.2	A24217
Silver	Approved Investigational	CDKN1A	1026	upregulated	Silver analog results in increased expression of CDKN1A mRNA	6p21.2	A24221 A24222
Silver	Approved Investigational	CHUK	1147	upregulated	Silver results in increased expression of CHUK mRNA	10q24.31	A24217
Silver	Approved Investigational	CNGB3	54714	downregulated	Silver results in decreased expression of CNGB3 mRNA	8q21.3	A24216
Silver	Approved Investigational	CNR1	1268	downregulated	Silver results in decreased expression of CNR1 mRNA	6q15	A24216
Silver	Approved Investigational	COLEC12	81035	downregulated	Silver results in decreased expression of COLEC12 mRNA	18p11.32	A24217
Silver	Approved Investigational	CXCL8	3576	downregulated	Silver analog results in decreased expression of CXCL8 mRNA	4q13.3	A24223
Silver	Approved Investigational	CXCL8	3576	upregulated	Silver analog results in increased expression of CXCL8 mRNA	4q13.3	A24224 A24225
Silver	Approved Investigational	DAG1	1605	downregulated	Silver results in decreased expression of DAG1 mRNA	3p21.31	A24216
Silver	Approved Investigational	DDX3Y	8653	downregulated	Silver results in decreased expression of DDX3Y mRNA	Yq11.221	A24216
Silver	Approved Investigational	DNAJC6	9829	upregulated	Silver results in increased expression of DNAJC6 mRNA	1p31.3	A24216
Silver	Approved Investigational	DSCAML1	57453	upregulated	Silver results in increased expression of DSCAML1 mRNA	11q23.3	A24216

Displaying entries 73826 - 73850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability